Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5604_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Carbon Based Nanomaterials for Drug Delivery
- •Preface
- •Acknowledgements
- •Contents
- •Editor and Contributors
- •Abbreviations
- •1.2 Market Statistics
- •Carbon-Based Nanomaterials: An Overview
- •1. Introduction
- •1.1 Evolution of Carbon-Based Nanomaterials
- •2. Carbon-Based Nanostructures
- •2.1 Fullerene
- •2.2 Carbon Nanotubes (CNTs)
- •2.4 Graphene
- •2.5 Nanodiamonds (NDs)
- •2.6 Nano-Onions (CNOs)
- •2.7 Nanohorns (CNHs)
- •2.8 Carbon Dots (CDs)
- •2.9 Nanoporous Activated Carbon
- •3. Synthesis Techniques
- •4. Properties of Carbon-Based Nanomaterials
- •4.1 Physicochemical Properties
- •4.2 Thermal Properties
- •4.3 Mechanical Properties
- •4.4 Optoelectronic Properties
- •4.5 Antimicrobial Properties
- •4.6 Biological Properties
- •5. Applications of Carbon-Based Nanomaterials
- •5.1 Environmental Remediation
- •5.2 Agriculture
- •5.3 Biofuel
- •5.4 Energy Storage
- •5.5 Biomedical Applications
- •6. Challenges and Future Perspectives
- •7. Concluding Remarks
- •References
- •Carbon-Based Nanostructured Materials: Designing, Properties and Applications
- •1. Introduction
- •2.1 Zero-Dimensional Carbon-Based Nanostructures (0D)
- •2.2 One-Dimensional Carbon-Based Nanostructures
- •2.3 Two-Dimensional (2D) Carbon-Based Nanostructures
- •2.4 Three-Dimensional (3D) Carbon-Based Nanostructures
- •3.1 Chemical Vapor Deposition
- •3.2 Hydrothermal and Solvothermal Techniques
- •3.3 Microwave-Assisted Technique
- •3.4 Chemical Oxidation Synthesis
- •4. Properties of Carbon-Based Nanostructured Materials
- •4.1 Thermal Properties
- •4.2 Mechanical Properties
- •4.3 Optoelectronic Properties
- •4.4 Antimicrobial Properties
- •4.5 Biological Properties
- •5. Applications of Carbon-Based Nanostructured Materials
- •5.2 Antibacterial and Antiviral Applications
- •5.3 Theragnostic
- •5.4 Wound Healing
- •5.5 Tissue Engineering
- •5.6 Drug Delivery
- •5.7 Biosensing
- •6. Challenges and Future Perspectives
- •7. Concluding Remarks
- •References
- •Drug Delivery System and Technologies
- •1. Introduction
- •2. Drug Delivery System
- •2.1 Conventional Drug Delivery System
- •2.2 Advanced Drug Delivery System
- •2.3 Controlled and Sustainable Drug Delivery System
- •3. Drug Delivery Technologies
- •3.1 Active and Passive Drug Delivery
- •3.2 Smart Drug Delivery
- •3.3 Intravenous and Extravaneous Drug Delivery
- •3.4 Various Types of Delivery Technologies
- •4. Challenges and Future Perspectives
- •5. Conclusion
- •References
- •Carbon-Based Nanomaterials for Drug Delivery: Past, Present, Future Directions
- •1. Introduction
- •3. Current Status in Drug Delivery by CNMs
- •3.1 Graphene-Based Nanomaterials in Drug Delivery
- •3.4 Nanodiamond Based Drug Delivery Systems
- •3.5 Nano-Onions in Drug Delivery
- •3.6 Nanohorns in Drug Delivery
- •3.7 Fullerene in Drug Delivery
- •4. Challenges and Future Perspective
- •5. Conclusions
- •References
- •Carbon Nanomaterial-Incorporated Supramolecular Drug Delivery
- •1. Introduction
- •2. Different Carbon Nanomaterials in Drug Delivery
- •2.1 Carbon Nanotubes (CNTs)
- •2.3 Graphene
- •2.4 Carbon Quantum Dots
- •2.5 Fullerene
- •2.6 Carbon Nanohorns
- •2.7 Carbon Nano-Onions
- •2.8 Nano-Diamond
- •3. Supramolecular Chemistry in Drug Delivery
- •3.1 Principles of Supramolecular Chemistry
- •3.3 Applications of Supramolecular Biomaterials
- •4. Carbon Nanomaterial-Incorporated Supramolecular Drug Delivery
- •5.1 Cyclodextrins
- •5.2 Calixarenes
- •5.3 Cucurbituril
- •5.4 Pillarenes
- •5.5 Crown Ether
- •6. Toxicity Concerns of Carbon Nanomaterials
- •7. Improving the Effectiveness of Nanoparticle Systems
- •8. Future of Nanomedicine
- •9.1 Challenges
- •9.2 Future Perspectives and Opportunities
- •9.3 Conclusions
- •References
- •Carbon Nanomaterial-Based Polymeric Nanocomposites for Drug Delivery
- •1. Introduction
- •2.1 Carbon Quantum Dot-Based Polymer Nanocomposite
- •2.2 Carbon Nanotube-Based Polymer Nanocomposite
- •2.3 Graphene Quantum Dot-Based Polymer Nanocomposite
- •2.5 Fullerene-Based Polymer Nanocomposite
- •2.6 Nanodiamond-Based Polymer Nanocomposite
- •3. Drug Delivery Systems Using Carbon Nanomaterial
- •3.1 Anticancer Drug Delivery
- •3.3 Infectious Disease Drug Delivery
- •3.4 Topical Drug Delivery
- •3.5 Brain Drug Delivery
- •3.6 Oral Drug Delivery
- •4. Challenge and Future Perspectives
- •5. Conclusion
- •References
- •Carbon Nanomaterial-Incorporated Polysaccharide-Based Nanocomposite for Drug Delivery
- •1. Introduction
- •1.1 Drug Delivery
- •1.2 Carbon Nanomaterials
- •1.3 Polysaccharide-Based Nanocomposite
- •2.1 CN-Incorporated Alginate-Based Nanocomposite
- •2.2 CN-Incorporated Cellulose-Based Nanocomposite
- •2.3 CN-Incorporated Chitosan-Based Nanocomposite
- •2.4 CN-Incorporated Dextran-Based Nanocomposite
- •2.5 CN-Incorporated Hyaluronic Acid-Based Nanocomposite
- •2.6 CN-Incorporated Starch-Based Nanocomposite
- •2.7 CN-Incorporated Pectin-Based Nanocomposite
- •2.8 CN-Incorporated Guar Gum-Based Nanocomposite
- •2.9 CN-Incorporated Agarose-Based Nanocomposite
- •2.10 CN-Incorporated Carrageenan-Based Nanocomposite
- •2.11 CN-Incorporated Glucomannan-Based Nanocomposite
- •3. Challenges and Future Prospective
- •4. Concluding Remarks
- •References
- •Graphene-Based Nanomaterials for Drug Delivery
- •1. Introduction
- •1.1 Challenges in Conventional Drug Delivery Systems
- •1.2 Overview of Nanomaterials for Drug Delivery
- •1.3 Role of Graphene-Based Nanomaterials in Drug Delivery
- •2. Synthesis of Graphene
- •2.1 Chemical Reduction Method
- •2.2 Thermal Reduction
- •2.3 Electrochemical Reduction
- •2.4 Chemical Vapor Deposition Method
- •2.5 Mechanical Exfoliation
- •2.6 Epitaxial Growth Method
- •2.7 Growth in Solvothermal and Hydrothermal Systems
- •2.8 Electrochemical Deposition
- •3. Types of Graphene-Based Materials
- •3.1 Graphene Quantum Dots, (GQDs)
- •3.2 Graphene Oxide (GO)
- •3.3 Graphene Nanoribbons (GNRs)
- •3.4 Oxidized Graphene Nanoribbons
- •4. Graphene Functionalized Materials for Drug Delivery
- •4.1 In Bone Tissue Regeneration
- •4.2 In Neural Regeneration
- •4.3 In Photodynamic and Photothermal Therapy
- •4.4 In Enhancing Cellular and Humoral Immunity
- •4.6 Miscellaneous
- •5. Challenges and Future Perspective
- •6. Conclusion
- •References
- •Carbon Quantum Dots Based Materials for Drug Delivery
- •1. Introduction
- •2. Synthesis Process of Carbon Quantum Dots
- •2.1 Top-Down Approaches
- •2.2 Bottom-Up Approaches
- •2.3 Microwave-Assisted Method
- •2.4 Electrochemical Method
- •2.5 Laser Ablation Method
- •2.6 Pyrolysis Method
- •2.7 Template-Assisted Method
- •4. Challenges and Future Perspective
- •5. Concluding Remarks
- •References
- •Carbon-based Nanocarriers for Sustained Drug Release in Dentistry
- •1. Introduction
- •2.1 Oral Mucosa Structure
- •2.2 Sites for Drug Delivery
- •2.3 Permeability
- •3. Local Drug Delivery for Dental Diseases
- •3.1 Odontogenic Infection
- •3.2 Non-odontogenic Infection
- •4. Bio-adhesive Nanoparticles: Novel Treatment Modality
- •4.1 Bio-adhesive Nanoparticles
- •4.2 Mechanism of Bioadhesion
- •5.1 Carbon Nanotubes
- •5.2 Graphene
- •5.3 Nanodiamonds
- •5.4 Fullerenes
- •5.5 Porous Carbon
- •5.6 Carbon Dots
- •6. Drug Delivery Systems Based on CBNs
- •6.2 Immediate Drug Delivery System (IDDS)
- •6.3 Sustained-release Drug Delivery Systems
- •6.4 Controlled Drug Delivery System (CDDs)
- •8. Conclusion
- •References
- •Fullerene Based Materials for Drug Delivery
- •1. Introduction
- •2. Types of Fullerene Derivatives
- •2.1 Exohedral Fullerene Derivatives
- •2.2 Endohedral Fullerene Derivatives
- •2.3 Surface Derivatized Fullerenes
- •3. Interaction of Fullerene Derivatives for Drug Delivery
- •4. Fullerene Based Materials for Drug Delivery
- •4.1 Nucleic Acid Delivery
- •4.2 Peptide Delivery
- •4.3 Topical Drug Delivery
- •4.4 Infectious Diseases Drug Delivery
- •4.5 Anticancer Drug Delivery
- •4.7 Brain Drug Delivery
- •4.8 Ocular Drug Delivery
- •5. Challenges and Future Perspectives
- •6. Concluding Remarks
- •6.1 Abbreviations
- •References
- •Graphene Quantum Dots-based Nanomaterials for Drug Delivery
- •1. Introduction
- •2. Synthesis of GQDs
- •3. GQD’s Properties for Drug Delivery
- •3.1 Optical Properties
- •3.2 Physicochemical Properties
- •3.3 Mechanical Properties
- •3.4 Biocompatibility and Cytotoxicity
- •4. Characterization of GQDs-Based Nanomaterials
- •4.1 Characterization of Multifunctional GQDs-Based Nanomaterials
- •5.1 Strategies for Developing Medication Delivery Systems Based on GQD
- •5.2 PH-responsive Drug Delivery Systems (GQD-DDSs)
- •5.3 Targeted Drug Delivery Using Ligand-Based GQDs as a Mediator
- •5.4 Improvement of Medicines’ Pharmacological Properties Using GQDs
- •5.5 Enhancing Cytotoxicity with GQD-DDS
- •7. Applications of Chiral GQDs
- •10. Challenges and Future Perspectives
- •11. Conclusions
- •References
- •Carbon Nano-onions for Drug Delivery
- •1. Introduction
- •2. Carbon Nano-Onion: A Multi-Layered Nanocarrier
- •3. Synthesis of Carbon Nano-Onions
- •3.1 Annealing Method
- •3.2 Carbon Ion Implantation Method
- •3.3 Arc Discharge Method
- •3.4 Carbon Vapour Deposition Method
- •3.5 Pyrolysis Method
- •6. Carbon Nano-Onions in Drug Delivery
- •6.1 Delivery of Therapeutic Agents
- •6.2 Delivery of Targeting Agents
- •6.3 Delivery of Imaging Agents
- •7. Challenges and Future Perspectives
- •8. Concluding Remarks
- •References
- •Chitosan/Carbon Nanocomposites in Drug Delivery and Cardiovascular Diseases
- •1. Introduction
- •1.1 Drug Delivery
- •1.2 Cardiovascular Diseases
- •1.3 Chitosan and Its Properties
- •1.4 Chitosan/Carbon Nanocomposites
- •2. Chitosan/Carbon Nanocomposites in Drug Delivery
- •3. Chitosan/Carbon Nanocomposites in CVDs
- •3.1 Chitosan-Based Scaffolds
- •3.2 Chitosan in Cardiac Tissue Engineering
- •3.3 Chitosan-Based Cell Therapy
- •3.4 Chitosan-Based Gene Delivery
- •3.5 Chitosan-Protein Interaction
- •4. Challenges and Future Perspective
- •5. Concluding Remarks
- •References
- •Graphene Reinforced Chitosan Nanocomposites for Drug Delivery
- •1. Introduction
- •2. Chitosan: Structure and Properties
- •3. Graphene: Structure, Types and Properties
- •4.1 Electrospinning Method
- •4.2 Sol–gel Method
- •4.3 Solution Mixing Method
- •4.4 In-situ Polymerization Method
- •5.2 Chitosan/Graphene Aerogels
- •5.3 Chitosan/Graphene Hydrogels
- •5.4 Chitosan/Graphene Thin Films
- •6.1 Oral Drug Delivery
- •6.2 Mucosal Drug Delivery
- •6.3 Transdermal Drug Delivery
- •6.4 Parenteral Drug Delivery
- •7. Challenges and Future Perspectives
- •8. Concluding Remarks
- •References
- •1. Introduction
- •2. Functionalization of CNFs
- •2.1 The Need for Functionalization

xxii Abbreviations
FA-COS Folic Acid–Chitosan Oligosaccharide Conjugate
FCM Flow Cytometric Analyses
FCNPs Fluorescent Carbon Nanoparticles
FDA Food and Drug Administration
Fe
3O4
Iron Oxide
FESEM Field Emission Scanning Electron Microscopy
FETs Field-Effect Transistors
FGQC Quantum Dot/Chitosan Nanocomposites
fGQDs Functionalized Graphene Quantum Dots
FI Fluorescein Isothiocyanate
FNDs Fluorescent Nanodiamonds
FOI Fluorescence Optical Imaging
FPC-NCs Fluorescent Porous Carbon-Nanocapsules
FRET Fluorescence Resonance Energy Transfer
FTIR Fourier Transform Infrared Spectroscopy
GC Glycol Chitosan
GC
1
Galactosylated Chitosan
GCN/g-CN Graphitic Carbon Nitride
Gd Gadolinium
GD-EMFs Gd-Endohedral Metallofullerenes
Gem Gemcitabine
GFP Green Fluorescent Protein
gGQDs Gold-Doped Graphene Quantum Dots
Gl Glucose
GLP-1 Glucagon-Like Peptide-1
GLUT5 Glucose Transporter Protein
GM Glycidyl Methacrylate
GML Glycerol Monolaurate
GNR Graphene Nanoribbons
GNS Graphene Nanosheets
GNTs Golden Nanotubes
GO Graphene Oxide
GOM Graphene Oxide Monomer
GONWs Graphene Oxide Nanowalls
GQDs Graphene Quantum Dots
GR Graphene
GRIS Griseofulvin
H
2
Hydrogen
HA Hyaluronic Acid
HA
1
Hydroxyapatite
HCoV-229E7 Human Coronavirus
HEK 293T Derivative of the Parent HEK (Human Embryonic Kidney)
293 Cell Line
HEK Human Embryonic Kidney
HFCVD Hot-Filament Chemical Vapor Deposition

Abbreviations xxiii
HFF Human Foreskin Fibroblasts
HGQD Hyaluronic Acid Graphene Quantum Dots
HIV-1 Immunodeficiency Virus
HN-1 TSPLNIHNGQKL
HO• Hydroxyl Radical
HOPG Highly Oriented Pyrolytic Graphite
HP Heparin-Poloxamer
HPCHS Hydroxypropyl Chitosan
HPG Hyperbranched Polyglycerol
HPHT High Pressure High Temperature
HPLC High-Performance Liquid Chromatography
HPMC Hydroxypropylmethyl Cellulose
HT-29 Human Colorectal Adenocarcinoma Cell Line
HU Hydroxyurea
IBP/IBU Ibuprofen
INDO Indomethacin
IONP Iron Oxide Nanoparticles
ITO Indium Tin Oxide
ITR Itraconazole
JAK2 V617F Janus Kinase 2 (JAK2) Mutation (V617F)
JNK c-Jun N-Terminal Kinase
KETO Ketoprofen
L-Arg L-Arginine
LbL Layer-by-Layer
LDH Lactate Dehydrogenase
LLC Lewis Lung Carcinoma
LMWH Low-Molecular-Weight Hydrogelators
LNA Locked Nucleic Acid
LOR Loratadine
LPS Lipopolysaccharides
LSV Linear Sweep Voltammetry
MAPKs Mitogen-Activated Protein Kinases
MCF Michigan Cancer Foundation
MDA-MB-231 The MDA-MB-231 cell line is an epithelial, human breast
cancer cell line that was established from a pleural effusion
of a 51-year-old Caucasian female with a metastatic
mammary adenocarcinoma1
MEL Meloxicam
MET-HCl Metoclopramide Hydrochloride
MG Magnetic Graphene Oxide
MGC Multinucleated Giant Cells
mGQDs Mangifera indica (mango)-Assisted Graphene Quantum
Dots
MIONPs Metal Iron Oxide NPs
MIP Molecularly Imprinted Polymer

xxiv Abbreviations
MMF Monomethyl Fumarate
MnO
2
Manganese Oxide
MOFs Metal-Organic Framework
MPa Mega Pascal
MPC Macro-porous Carbon
mPEG Methoxy Polyethylene Glycol Amine
MRI Magnetic Resonance Imaging
MRI-CA Magnetic Resonance Imaging Contrast Agents
MRSA Methicillin-Resistant S. aureus
MTT 3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyl Tetrazolium
Bromide
MTX Methotrexate
MWCNT Multi-walled Carbon Nanotube
MWNT Multi-Walled Nanotube
N
2H4
NaBH
NaNO
4
3
Hydrazine
Sodium Borohydrate
Sodium Nitrate
NAP Naproxen
N-CQDs Nitrogen-Doped Carbon Quantum Dots
ND/NDs Nanodiamonds
ND-OH Hydroxylated Nanodiamond
NDs Nanodiamonds
N-GQDs Nitrogen-Doped GQDs
NiO Nickel Oxide
NIR Near Infrared
NMR Nuclear Magnetic Resonance
NMRD Nuclear Magnetic Relaxation Dispersion
NP Nanoparticle
NPCP Fluorescent Iron Oxide Nanoparticle
ns Nanoseconds
NSC Neural Stem Dell
NSCLC Non-small-Cell Lung Carcinoma
NU Nitrosourea
•
O
2
Superoxide Radical
OAL Oxidized Sodium Alginate
OCMC O-Carboxymethyl Chitosan
OECD Organization for Economic Co-operation and Development
OH Hydroxyl
O-SWCNTs Oxidized Single-Walled Carbon Nanotubes
PA Peptide Amphiphile
PAA Poly(acrylic acid)
PAN Poly(acrylonitrile)
PB Probucol
PCFD-Fl Polyanionic Fullerene Derivative with Fluorescein
PCL Polycaprolactone/Poly(ε-caprolactone)

Abbreviations xxv
PD Parkinson’s Disease
PDT Photodynamic Therapy
PEG Polyethylene Glycol
PEGS-PBA-BA Polyethylene Glycol-co-poly (glycerol sebacic acid)
Difunctionalized with Phenylboronic Acid and
Benzaldehyde
PEI Polyethyleneimine
PEO Poly(ethylene oxide)
PET Polyethylene Terephthalate
PHAs Polyhydroxyalkanoates
PHCNs Porous Hollow Carbon Nanospheres
PL Photoluminescence
PLA Polylactic Acid
PLGA Poly(lactic-co-glycolic acid)
PLLA Poly(L-lactic acid)
PL-PEG Phospholipid-Bearing Polyethylene Glycol
PNIPAM Poly(N-isopropylacrylamide)
Pt (IV) Platinum (IV)
PTT Photothermal Therapy
PTT
1
Photothermal Treatment
PTX Paclitaxel
PU Poly(urethane)
PVA/PVAL Poly Vinyl Alcohol
PVDF Polyvinylidene Fluoride
PVP Polyvinylpyrrolidone/Poly(vinylpyrrolidone)
QC Quercetin
QCSG Glycidyl Methacrylate Functionalized Quaternized
Chitosan
QDs Quantum Dots
QSAR Quantitative Structure–Activity Relationship
RES Reticuloendothelial System
RFN Riboflavin
RGD Arginylglycylaspartic Acid
RGNWs Reduced Graphene Nanowalls
rGO Reduced Graphene Oxide
rGO@PDA Polydopamine-Coated rGO
RGQD Reduced Graphene Oxide Quantum Dots
RNA Ribonucleic Acid
ROS Reactive Oxygen Species
S42 Schwann Cells
SA Sodium Alginate
SCENIHR Scientific Committee on Emerging and Newly Identified
Health Risks
SDS Sodium Dodecyl Sulfate
SEM Scanning Electron Microscope

xxvi Abbreviations
SERS Surface-Enhanced Raman scattering
sEV Small Extracellular Vesicles
SiC Silicon Carbide
Sil Silibinin
SiO
2
Silicon Dioxide
siRNA Small Interfering Ribonucleic Acid
SLG Single-Layer Graphene
SOF Supramolecular Organic Framework
SPION Superparamagnetic Iron Oxide Nanoparticles
SPIRO Spirolactone
SPR Surface Plasmon Resonance
SUM Sumatriptan
SWCNH/SWNH Single-Walled Carbon Nanohorns
SWCNHs Single-Walled Carbon Nanohorns
SWCNT Single-Walled Carbon Nanotube
SWNT Single-Walled Nanotube
TBAH Tetrabutylammonium Hydroxide
TCH Tetracycline Hydrochloride
TCN Tetracycline
TDF Tenofovir Disoproxil Fumarate
TEM Transmission Electron Microscope
TGA Thermogravimetric Analysis
THF Tetrahydrofuran
TiO
2
Titanium Dioxide
TLC Thin Layer Chromatography
TMOMCN Thermo-sensitively and Magnetically Ordered
Mesoporous Carbon Nanospheres
TMZ Temozolomide
TNT Trimetallic Nitride Template
TP Thiotepa
TPFE Tetra(piperazino)fullerene Epoxide
TPN@F and TPS@F Thiotepa North Head Fullerene and Thiotepa South Head
Fullerene
TPP/TTP Tripolyphosphate
UCNPs Upconverted Nanophosphorites
UPLC Ultra-Performance Liquid Chromatography
UVA Ultraviolet A
UVB Ultraviolet B
UV-Vis UV–Vis Spectrophotometer
VEGF Vascular Endothelial Growth Factor
VSM Vibrating Sample Magnetometer
VSV Vesicular Stomatitis Virus
W-GQDs White-Light-Emitting Graphene Quantum Dots
WST Water-Soluble Tetrazolium
XPS X-ray Photoelectron Spectroscopy

Abbreviations xxvii
XRD X-ray Diffractometer
ZIF Zeolite Imidazole Framework
ZIF-8 Zeolitic Imidazolate Framework-8
ZnO Zinc Oxide
ZOL-GO Graphene Oxide-Zoledronic Acid
ZrO
2
Zirconium Dioxide

Carbon-Based Nanomaterials: An Overview
Sarat Kumar Swain, Anuradha Biswal, Swapnita Patra,
and Krishna Manjari Sahu
Abstract In present chapter, the evolution of carbon-based nanomaterials (CNMs) is
elaborately discussed. The structure performance relationship based upon the unique
properties of CNMs is established. The synthesis of CNMs is briefly predicted with
schematic representation. The preliminary idea regarding nanohorns, nanodiamonds,
and nano-onions is presented in the chapter whose applications in detail are extensively investigated in different chapters of this book. This chapter is concluded with
predicting various applications of CNMs. Out of different applications, CNMs as
drug delivery vehicles are the main motivation of this book.
Keywords Carbon nanomaterials
remediation
· Bio fuel · Biomedical applications
Physiochemical properties·Environmental
·
Abbreviations
ATP Adenosine triphosphate
CAGR Compound annual growth rate
CDs Carbon dots
CNFs Carbon nanofibers
CNHs Carbon nanohorns
CNMs Carbon-based nanomaterials
CNOs Carbon nano-onions
CNTs Carbon nanotubes
CPT Camptothecin
CQDs Carbon quantum dots
CVD Chemical vapour deposition
DNA Deoxyribonucleic acid
DOX Doxorubicin
S. K. Swain (B) · A. Biswal · S. Patra · K. M. Sahu
Department of Chemistry, Veer Surendra Sai University of Technology, Burla, Sambalpur 768018,
Odisha, India
e-mail: skswain_chem@vssut.ac.in
1

2 S.K.Swainetal.
DWCNTs Double-walled carbon nanotubes
EPR Enhanced permeability and retention
FETs Field-effect transistors
g-CN Graphitic carbon nitride
GO Graphene oxide
GONWs Graphene oxide nanowalls
HFCVD Hot-filament chemical vapour deposition
HPHT High-pressure high-temperature
MWCNTs Multiwalled carbon nanotubes
NDs Nanodiamonds
PLGA Poly(lactic-co-glycolic acid)
RGNWs Reduced graphene nanowalls
rGO Reduced graphene oxide
RNA Ribonucleic acid
ROS Reactive oxygen species
SLG Single-layer graphene
SWCNHs Single-walled carbon nanohorns
SWCNTs Single-walled carbon nanotubes
TEM Transmission electron microscope
TNT Trinitrotoluene
ZIF Zeolite imidazole framework
1 Introduction
Carbon, one of the most primitive elements and rightly known as “the key element
of living substance”, continues to fascinate the world with its miraculous potential to
transform into various forms aided by its various hybridization modes, i.e. sp, sp
3
[1]. This particular attribute allows carbon to generate myriad structural forms
sp
that proclaims its importance worldwide, for instance, carbon is the backbone of the
Fischer–Tropsch process employed by Sasol, South Africa to manufacture chemicals and fuels. However, its affinity to form strong bonds with oxygen to produce
, which can lead to creation of a carbon, sink, uncovering the “dark side” of the
CO
2
element. Hence, prior knowledge regarding controlling the bonding characteristics
of this remarkable element becomes essential for harnessing the unmatched potential of carbon for betterment of the society. Carbon, with four valence electrons, can
form an array of bonds with other carbon atoms giving rise to C–C, C =C and C≡C
interactions. The ability to regulate the formation of all carbon structures, especially
with C=C networking structures, with different properties has helped to harness
the power of carbon chemistry in putting the stepping stone towards evolution of
CNMs or carbonaceous nanomaterials. Fullerenes are the first ever CNMs discovered by Kroto et al. [2], which serves as a benchmark in material science followed
by extensive studies on carbon nanotubes (CNTs) by Iijima [3]. These discoveries
2
and

Carbon-Based Nanomaterials: An Overview 3
paved pathway for the third isotope of carbon with bent sp2hybridization, following
diamond and graphite. These developments in the field of carbonaceous materials
paralleled with trials to miniaturize devices and the need for developing novel characterization tools to study these marvellous structures put the stepping stone towards
emergence of nanotechnology. From the onset of research on CNMs until the present
age, CNMs have bloomed into a class of highly functional materials and they are
extensively highlighted due to their tremendous versatility. CNMs exhibit unparalleled electrical, thermal, mechanical and chemical traits, along with the high abundance and diverse forms of carbon, which opens new window for the nanomaterials
to be utilized in a plethora of applications [4]. In order to understand the progress of
CNMs, it is crucial to discuss its evolution from basic and primitive sources to the
giant it is today, in the world of material science.
1.1 Evolution of Carbon-Based Nanomaterials
To know about the details regarding the increased popularity of CNMs, it is necessary
to study the storyline behind evolutionof CNMs. The story traces back to 1984 when
Smalley, Institute for Nanoscale Science and Technologyof Rice University,Houston
got a request from Harold Kroto of University of Sussex to use the laser supersonic
cluster beam machine in Smalley’s laboratory to investigate a special type of carbon
molecule [5]. To this, R. Smalley replied in great enthusiasm, “In retrospect, I seem
to have been fascinated by various peculiar aspects of carbon chemistry for much of
my research career [6]”. This conversation laid the foundation to the ground-breaking
discoveryof fullerenes (C60) otherwise popularly knownas “Buckminsterfullerenes”
which eventually bagged them the Nobel prize for chemistry in 1996. This was
followed by the discovery of hollow nano-dimensional tubular structures of graphitic
carbon by Sumio Iijima, Nippon Electric Company (NEC) Corporation in 1991. His
discovery initiated a whirlwind in research in carbon chemistry, which inspired many
scientists to take up further research on this highly functional form of CNMs. Moving
forward in the timeline of CNMs evolution (Fig. 1), graphene was the next major
achievement in the field of carbonaceous nanomaterials. Though the term graphene
was first coined in 1986 by German chemists Ralph Setton, Hanns-Peter Boehm
and Eberhard Stumpp, the first successful isolation of a single atom thick layer of
crystallite was done from graphite by Geim and Novoselov [7]. This phenomenon
not only introduced a highly resilient form of carbon material to the scientific society,
but was also awarded Nobel Prize for physics in 2010. These important milestones
in the journey of CNMs have established CNMs as a cornerstone in material science.

4 S.K.Swainetal.
Fig. 1 Evolution timeline of CNMs
1.2 Market Statistics
The global CNMs market is valued at $2.9 billion in 2021 and is expected to be
estimated to reach an elevated figure of $31.6 billion in the next 10 years with
an increasing 27.7% Compound Annual Growth Rate (CAGR). The overall global
market of CNMs is divided based on forms of CNMs and regions. Based on various
forms, the market is divided into nanofibers, graphene, fullerenes, CNTs and many
more. Based on region, the market is mainly studied across Europe, North America,
South America, Middle East-Africa and Asia–Pacific. The fullerenes owned the
largest market share of 93.2%, attributing to its wide applicability in electronics.
Graphene segment witnessed fastest growth of about 31% CAGR due to elevated
demand of graphene in energy and automobile industries. Whereas the Asia–Pacific
accounted for 27.9% share in 2021 and is on the stipulated growth trajectory of 29.1%
CAGR.
Соседние файлы в папке Библиотека им академика М.И. Перельмана
